Carregant...
SOMATOSTATIN RECEPTOR SUBTYPE 2A IMMUNOHISTOCHEMISTRY USING A NEW MONOCLONAL ANTIBODY SELECTS TUMORS SUITABLE FOR IN VIVO SOMATOSTATIN RECEPTOR TARGETING
High over-expression of somatostatin receptors in neuroendocrine tumors allows imaging and radiotherapy with radiolabelled somatostatin analogues. To know if a tumor is suitable for in vivo somatostatin receptor targeting, its somatostatin receptor expression has to be determined. There are specific...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3261429/ https://ncbi.nlm.nih.gov/pubmed/22251942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAS.0b013e31823d07f3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|